AxoSim, Inc.

AxoSim empowers advancements in human neuroscience and is mission-driven to advance 3-D organoid neurodiscovery models, also known as microphysiological systems, with the potential to jumpstart the discovery and development of breakthrough therapies. Partnering with biopharma companies, AxoSim facilitates therapeutic innovation by empowering drug developers to obtain relevant human data early in the R&D process, reducing the time and cost of drug discovery and increasing the probability of success. The company’s proprietary drug discovery platforms NerveSim®, BrainSim® and microBrain™ deliver clinically relevant functional data, enabling selection of better lead candidates with phenotypically accurate assays. AxoSim's platforms currently have applications in peripheral neuropathy and neuropathic pain, multiple sclerosis, seizure disorders, neurotoxicology, and other diseases. For more information, visit www.axosim.com. 

Industries

Biotechnology

Office Locations

New Orleans, Louisiana